ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Weight Loss Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-30F1883
Home | Market Reports | Health| Pharmacy
Global Weight Loss Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Weight Loss Drugs Market Research Report 2025

Code: QYRE-Auto-30F1883
Report
August 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Company
Roche
GSK Group
TEVA
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal
National Company For Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
Zein Pharmaceutical
HISUN
Taj Pharmaceuticals Ltd.
Kabir Life Sciences & Research
DM Pharma
China Zhongshan Pharm

Weight Loss Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Weight Loss Drugs Market

Weight Loss Drugs Market

The global market for Weight Loss Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Weight Loss Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Weight Loss Drugs.
The Weight Loss Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Tablets) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Weight Loss Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Weight Loss Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Weight Loss Drugs Market Report

Report Metric Details
Report Name Weight Loss Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Weight-reducing Aid
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company For Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation, Zein Pharmaceutical, Hisun, Taj Pharmaceuticals Ltd, Kabir Life Sciences & Research, Dm Pharma, China Zhongshan Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Weight Loss Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Weight Loss Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Weight Loss Drugs Market report?

Ans: The main players in the Weight Loss Drugs Market are Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company For Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation, Zein Pharmaceutical, Hisun, Taj Pharmaceuticals Ltd, Kabir Life Sciences & Research, Dm Pharma, China Zhongshan Pharm

What are the Application segmentation covered in the Weight Loss Drugs Market report?

Ans: The Applications covered in the Weight Loss Drugs Market report are Weight-reducing Aid, Other

What are the Type segmentation covered in the Weight Loss Drugs Market report?

Ans: The Types covered in the Weight Loss Drugs Market report are Liauid Weight Loss Drugs, Tablets Weight Loss Drugs

Recommended Reports

Pharmaceutical Drug Markets

CNS & Mental Health

Diagnostics & Services

1 Weight Loss Drugs Market Overview
1.1 Product Definition
1.2 Weight Loss Drugs by Type
1.2.1 Global Weight Loss Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liauid Weight Loss Drugs
1.2.3 Tablets Weight Loss Drugs
1.3 Weight Loss Drugs by Application
1.3.1 Global Weight Loss Drugs Market Value by Application (2024 VS 2031)
1.3.2 Weight-reducing Aid
1.3.3 Other
1.4 Global Weight Loss Drugs Market Size Estimates and Forecasts
1.4.1 Global Weight Loss Drugs Revenue 2020-2031
1.4.2 Global Weight Loss Drugs Sales 2020-2031
1.4.3 Global Weight Loss Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Weight Loss Drugs Market Competition by Manufacturers
2.1 Global Weight Loss Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Weight Loss Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Weight Loss Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Weight Loss Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Weight Loss Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Weight Loss Drugs, Product Type & Application
2.7 Global Key Manufacturers of Weight Loss Drugs, Date of Enter into This Industry
2.8 Global Weight Loss Drugs Market Competitive Situation and Trends
2.8.1 Global Weight Loss Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Weight Loss Drugs Players Market Share by Revenue
2.8.3 Global Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Weight Loss Drugs Market Scenario by Region
3.1 Global Weight Loss Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Weight Loss Drugs Sales by Region: 2020-2031
3.2.1 Global Weight Loss Drugs Sales by Region: 2020-2025
3.2.2 Global Weight Loss Drugs Sales by Region: 2026-2031
3.3 Global Weight Loss Drugs Revenue by Region: 2020-2031
3.3.1 Global Weight Loss Drugs Revenue by Region: 2020-2025
3.3.2 Global Weight Loss Drugs Revenue by Region: 2026-2031
3.4 North America Weight Loss Drugs Market Facts & Figures by Country
3.4.1 North America Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Weight Loss Drugs Sales by Country (2020-2031)
3.4.3 North America Weight Loss Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Weight Loss Drugs Market Facts & Figures by Country
3.5.1 Europe Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Weight Loss Drugs Sales by Country (2020-2031)
3.5.3 Europe Weight Loss Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Weight Loss Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Weight Loss Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Weight Loss Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Weight Loss Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Weight Loss Drugs Market Facts & Figures by Country
3.7.1 Latin America Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Weight Loss Drugs Sales by Country (2020-2031)
3.7.3 Latin America Weight Loss Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Weight Loss Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Weight Loss Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Weight Loss Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Weight Loss Drugs Sales by Type (2020-2031)
4.1.1 Global Weight Loss Drugs Sales by Type (2020-2025)
4.1.2 Global Weight Loss Drugs Sales by Type (2026-2031)
4.1.3 Global Weight Loss Drugs Sales Market Share by Type (2020-2031)
4.2 Global Weight Loss Drugs Revenue by Type (2020-2031)
4.2.1 Global Weight Loss Drugs Revenue by Type (2020-2025)
4.2.2 Global Weight Loss Drugs Revenue by Type (2026-2031)
4.2.3 Global Weight Loss Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Weight Loss Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Weight Loss Drugs Sales by Application (2020-2031)
5.1.1 Global Weight Loss Drugs Sales by Application (2020-2025)
5.1.2 Global Weight Loss Drugs Sales by Application (2026-2031)
5.1.3 Global Weight Loss Drugs Sales Market Share by Application (2020-2031)
5.2 Global Weight Loss Drugs Revenue by Application (2020-2031)
5.2.1 Global Weight Loss Drugs Revenue by Application (2020-2025)
5.2.2 Global Weight Loss Drugs Revenue by Application (2026-2031)
5.2.3 Global Weight Loss Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Weight Loss Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Weight Loss Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 GSK group
6.2.1 GSK group Company Information
6.2.2 GSK group Description and Business Overview
6.2.3 GSK group Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK group Weight Loss Drugs Product Portfolio
6.2.5 GSK group Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Weight Loss Drugs Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sandoz(Novartis)
6.4.1 Sandoz(Novartis) Company Information
6.4.2 Sandoz(Novartis) Description and Business Overview
6.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sandoz(Novartis) Weight Loss Drugs Product Portfolio
6.4.5 Sandoz(Novartis) Recent Developments/Updates
6.5 STADA-VN J.V.Co., Ltd
6.5.1 STADA-VN J.V.Co., Ltd Company Information
6.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
6.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 STADA-VN J.V.Co., Ltd Weight Loss Drugs Product Portfolio
6.5.5 STADA-VN J.V.Co., Ltd Recent Developments/Updates
6.6 Hexal AG
6.6.1 Hexal AG Company Information
6.6.2 Hexal AG Description and Business Overview
6.6.3 Hexal AG Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hexal AG Weight Loss Drugs Product Portfolio
6.6.5 Hexal AG Recent Developments/Updates
6.7 National Company For Pharmaceutical Industry
6.7.1 National Company For Pharmaceutical Industry Company Information
6.7.2 National Company For Pharmaceutical Industry Description and Business Overview
6.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 National Company For Pharmaceutical Industry Weight Loss Drugs Product Portfolio
6.7.5 National Company For Pharmaceutical Industry Recent Developments/Updates
6.8 Lunan Pharmaceutical Group Corporation
6.8.1 Lunan Pharmaceutical Group Corporation Company Information
6.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
6.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product Portfolio
6.8.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
6.9 Zein Pharmaceutical
6.9.1 Zein Pharmaceutical Company Information
6.9.2 Zein Pharmaceutical Description and Business Overview
6.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zein Pharmaceutical Weight Loss Drugs Product Portfolio
6.9.5 Zein Pharmaceutical Recent Developments/Updates
6.10 Hisun
6.10.1 Hisun Company Information
6.10.2 Hisun Description and Business Overview
6.10.3 Hisun Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hisun Weight Loss Drugs Product Portfolio
6.10.5 Hisun Recent Developments/Updates
6.11 Taj Pharmaceuticals Ltd
6.11.1 Taj Pharmaceuticals Ltd Company Information
6.11.2 Taj Pharmaceuticals Ltd Description and Business Overview
6.11.3 Taj Pharmaceuticals Ltd Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Taj Pharmaceuticals Ltd Weight Loss Drugs Product Portfolio
6.11.5 Taj Pharmaceuticals Ltd Recent Developments/Updates
6.12 Kabir Life Sciences & Research
6.12.1 Kabir Life Sciences & Research Company Information
6.12.2 Kabir Life Sciences & Research Description and Business Overview
6.12.3 Kabir Life Sciences & Research Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Kabir Life Sciences & Research Weight Loss Drugs Product Portfolio
6.12.5 Kabir Life Sciences & Research Recent Developments/Updates
6.13 Dm Pharma
6.13.1 Dm Pharma Company Information
6.13.2 Dm Pharma Description and Business Overview
6.13.3 Dm Pharma Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dm Pharma Weight Loss Drugs Product Portfolio
6.13.5 Dm Pharma Recent Developments/Updates
6.14 China Zhongshan Pharm
6.14.1 China Zhongshan Pharm Company Information
6.14.2 China Zhongshan Pharm Description and Business Overview
6.14.3 China Zhongshan Pharm Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 China Zhongshan Pharm Weight Loss Drugs Product Portfolio
6.14.5 China Zhongshan Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Weight Loss Drugs Industry Chain Analysis
7.2 Weight Loss Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Weight Loss Drugs Production Mode & Process Analysis
7.4 Weight Loss Drugs Sales and Marketing
7.4.1 Weight Loss Drugs Sales Channels
7.4.2 Weight Loss Drugs Distributors
7.5 Weight Loss Drugs Customer Analysis
8 Weight Loss Drugs Market Dynamics
8.1 Weight Loss Drugs Industry Trends
8.2 Weight Loss Drugs Market Drivers
8.3 Weight Loss Drugs Market Challenges
8.4 Weight Loss Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Company
Roche
GSK Group
TEVA
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal
National Company For Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
Zein Pharmaceutical
HISUN
Taj Pharmaceuticals Ltd.
Kabir Life Sciences & Research
DM Pharma
China Zhongshan Pharm
List of Tables
 Table 1. Global Weight Loss Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Weight Loss Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Weight Loss Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Weight Loss Drugs Sales (K Tablets) of Key Manufacturers (2020-2025)
 Table 5. Global Weight Loss Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Weight Loss Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Weight Loss Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Weight Loss Drugs Average Price (USD/Tablet) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Weight Loss Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Weight Loss Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Weight Loss Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Weight Loss Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Weight Loss Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Weight Loss Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Weight Loss Drugs Sales by Region (2020-2025) & (K Tablets)
 Table 18. Global Weight Loss Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Weight Loss Drugs Sales by Region (2026-2031) & (K Tablets)
 Table 20. Global Weight Loss Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Weight Loss Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Weight Loss Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Weight Loss Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Weight Loss Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Weight Loss Drugs Sales by Country (2020-2025) & (K Tablets)
 Table 27. North America Weight Loss Drugs Sales by Country (2026-2031) & (K Tablets)
 Table 28. North America Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Weight Loss Drugs Sales by Country (2020-2025) & (K Tablets)
 Table 32. Europe Weight Loss Drugs Sales by Country (2026-2031) & (K Tablets)
 Table 33. Europe Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Weight Loss Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Weight Loss Drugs Sales by Region (2020-2025) & (K Tablets)
 Table 37. Asia Pacific Weight Loss Drugs Sales by Region (2026-2031) & (K Tablets)
 Table 38. Asia Pacific Weight Loss Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Weight Loss Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Weight Loss Drugs Sales by Country (2020-2025) & (K Tablets)
 Table 42. Latin America Weight Loss Drugs Sales by Country (2026-2031) & (K Tablets)
 Table 43. Latin America Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Weight Loss Drugs Sales by Country (2020-2025) & (K Tablets)
 Table 47. Middle East and Africa Weight Loss Drugs Sales by Country (2026-2031) & (K Tablets)
 Table 48. Middle East and Africa Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Weight Loss Drugs Sales (K Tablets) by Type (2020-2025)
 Table 51. Global Weight Loss Drugs Sales (K Tablets) by Type (2026-2031)
 Table 52. Global Weight Loss Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Weight Loss Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Weight Loss Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Weight Loss Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Weight Loss Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Weight Loss Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Weight Loss Drugs Price (USD/Tablet) by Type (2020-2025)
 Table 59. Global Weight Loss Drugs Price (USD/Tablet) by Type (2026-2031)
 Table 60. Global Weight Loss Drugs Sales (K Tablets) by Application (2020-2025)
 Table 61. Global Weight Loss Drugs Sales (K Tablets) by Application (2026-2031)
 Table 62. Global Weight Loss Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Weight Loss Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Weight Loss Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Weight Loss Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Weight Loss Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Weight Loss Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Weight Loss Drugs Price (USD/Tablet) by Application (2020-2025)
 Table 69. Global Weight Loss Drugs Price (USD/Tablet) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 73. Roche Weight Loss Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. GSK group Company Information
 Table 76. GSK group Description and Business Overview
 Table 77. GSK group Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 78. GSK group Weight Loss Drugs Product
 Table 79. GSK group Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 83. Teva Weight Loss Drugs Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Sandoz(Novartis) Company Information
 Table 86. Sandoz(Novartis) Description and Business Overview
 Table 87. Sandoz(Novartis) Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 88. Sandoz(Novartis) Weight Loss Drugs Product
 Table 89. Sandoz(Novartis) Recent Developments/Updates
 Table 90. STADA-VN J.V.Co., Ltd Company Information
 Table 91. STADA-VN J.V.Co., Ltd Description and Business Overview
 Table 92. STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 93. STADA-VN J.V.Co., Ltd Weight Loss Drugs Product
 Table 94. STADA-VN J.V.Co., Ltd Recent Developments/Updates
 Table 95. Hexal AG Company Information
 Table 96. Hexal AG Description and Business Overview
 Table 97. Hexal AG Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 98. Hexal AG Weight Loss Drugs Product
 Table 99. Hexal AG Recent Developments/Updates
 Table 100. National Company For Pharmaceutical Industry Company Information
 Table 101. National Company For Pharmaceutical Industry Description and Business Overview
 Table 102. National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 103. National Company For Pharmaceutical Industry Weight Loss Drugs Product
 Table 104. National Company For Pharmaceutical Industry Recent Developments/Updates
 Table 105. Lunan Pharmaceutical Group Corporation Company Information
 Table 106. Lunan Pharmaceutical Group Corporation Description and Business Overview
 Table 107. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 108. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product
 Table 109. Lunan Pharmaceutical Group Corporation Recent Developments/Updates
 Table 110. Zein Pharmaceutical Company Information
 Table 111. Zein Pharmaceutical Description and Business Overview
 Table 112. Zein Pharmaceutical Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 113. Zein Pharmaceutical Weight Loss Drugs Product
 Table 114. Zein Pharmaceutical Recent Developments/Updates
 Table 115. Hisun Company Information
 Table 116. Hisun Description and Business Overview
 Table 117. Hisun Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 118. Hisun Weight Loss Drugs Product
 Table 119. Hisun Recent Developments/Updates
 Table 120. Taj Pharmaceuticals Ltd Company Information
 Table 121. Taj Pharmaceuticals Ltd Description and Business Overview
 Table 122. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 123. Taj Pharmaceuticals Ltd Weight Loss Drugs Product
 Table 124. Taj Pharmaceuticals Ltd Recent Developments/Updates
 Table 125. Kabir Life Sciences & Research Company Information
 Table 126. Kabir Life Sciences & Research Description and Business Overview
 Table 127. Kabir Life Sciences & Research Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 128. Kabir Life Sciences & Research Weight Loss Drugs Product
 Table 129. Kabir Life Sciences & Research Recent Developments/Updates
 Table 130. Dm Pharma Company Information
 Table 131. Dm Pharma Description and Business Overview
 Table 132. Dm Pharma Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 133. Dm Pharma Weight Loss Drugs Product
 Table 134. Dm Pharma Recent Developments/Updates
 Table 135. China Zhongshan Pharm Company Information
 Table 136. China Zhongshan Pharm Description and Business Overview
 Table 137. China Zhongshan Pharm Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2020-2025)
 Table 138. China Zhongshan Pharm Weight Loss Drugs Product
 Table 139. China Zhongshan Pharm Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Weight Loss Drugs Distributors List
 Table 143. Weight Loss Drugs Customers List
 Table 144. Weight Loss Drugs Market Trends
 Table 145. Weight Loss Drugs Market Drivers
 Table 146. Weight Loss Drugs Market Challenges
 Table 147. Weight Loss Drugs Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Weight Loss Drugs
 Figure 2. Global Weight Loss Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Weight Loss Drugs Market Share by Type: 2024 & 2031
 Figure 4. Liauid Weight Loss Drugs Product Picture
 Figure 5. Tablets Weight Loss Drugs Product Picture
 Figure 6. Global Weight Loss Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Weight Loss Drugs Market Share by Application: 2024 & 2031
 Figure 8. Weight-reducing Aid
 Figure 9. Other
 Figure 10. Global Weight Loss Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Weight Loss Drugs Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Weight Loss Drugs Sales (2020-2031) & (K Tablets)
 Figure 13. Global Weight Loss Drugs Average Price (USD/Tablet) & (2020-2031)
 Figure 14. Weight Loss Drugs Report Years Considered
 Figure 15. Weight Loss Drugs Sales Share by Manufacturers in 2024
 Figure 16. Global Weight Loss Drugs Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Weight Loss Drugs Players: Market Share by Revenue in Weight Loss Drugs in 2024
 Figure 18. Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Weight Loss Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Weight Loss Drugs Sales Market Share by Country (2020-2031)
 Figure 21. North America Weight Loss Drugs Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Weight Loss Drugs Sales Market Share by Country (2020-2031)
 Figure 25. Europe Weight Loss Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Weight Loss Drugs Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Weight Loss Drugs Revenue Market Share by Region (2020-2031)
 Figure 33. China Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Weight Loss Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Weight Loss Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Weight Loss Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Weight Loss Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Weight Loss Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Weight Loss Drugs by Type (2020-2031)
 Figure 55. Global Weight Loss Drugs Price (USD/Tablet) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Weight Loss Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Weight Loss Drugs by Application (2020-2031)
 Figure 58. Global Weight Loss Drugs Price (USD/Tablet) by Application (2020-2031)
 Figure 59. Weight Loss Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Prescription Weight Loss Medications Market Research Report 2025
Global Weight Reduction Medicine Market Research Report 2024
Global Hair Loss Growth Treatment Market Research Report 2025
Hair Loss Treatment for Man Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cholesterol Reducer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cholesterol Lowering Drugs Market Research Report 2024
Diet Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lipid lowering Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidepressant Medication Market Research Report 2025
Global Immune Drugs Market Insights Forecast to 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gynecological Cancers Drug Market Research Report 2025
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression MDD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions